BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6815190)

  • 1. Adenosine deaminase from deoxycoformycin-sensitive and -resistant rat hepatoma cells. Purification and characterization.
    Hunt SW; Hoffee PA
    J Biol Chem; 1982 Dec; 257(23):14239-44. PubMed ID: 6815190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of adenosine deaminase gene sequences in deoxycoformycin-resistant rat hepatoma cells.
    Hunt SW; Hoffee PA
    J Biol Chem; 1983 Nov; 258(21):13185-92. PubMed ID: 6605347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased adenosine deaminase synthesis and messenger RNA activity in deoxycoformycin-resistant cells.
    Hunt SW; Hoffee PA
    J Biol Chem; 1983 Jan; 258(1):41-4. PubMed ID: 6600234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of deoxycoformycin-resistant cells with increased levels of adenosine deaminase.
    Hoffee PA; Hunt SW; Chiang J
    Somatic Cell Genet; 1982 Jul; 8(4):465-77. PubMed ID: 6981855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine deaminase gene amplification in deoxycoformycin-resistant mammalian cells.
    Rowland P; Pfeilsticker J; Hoffee PA
    Arch Biochem Biophys; 1985 Jun; 239(2):396-403. PubMed ID: 3873908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of adenosine deaminase from a genetically enriched mouse cell line.
    Ingolia DE; Yeung CY; Orengo IF; Harrison ML; Frayne EG; Rudolph FB; Kellems RE
    J Biol Chem; 1985 Oct; 260(24):13261-7. PubMed ID: 3902813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxycoformycin resistant mammalian cells that overproduce adenosine deaminase.
    Hoffee PA; Hunt SW
    Adv Exp Med Biol; 1984; 165 Pt A():405-10. PubMed ID: 6609531
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor.
    Ratech H; Thorbecke GJ; Hirschhorn R
    Clin Immunol Immunopathol; 1981 Oct; 21(1):119-27. PubMed ID: 6268339
    [No Abstract]   [Full Text] [Related]  

  • 9. Spontaneous epimerization of (S)-deoxycoformycin and interaction of (R)-deoxycoformycin, (S)-deoxycoformycin, and 8-ketodeoxycoformycin with adenosine deaminase.
    Schramm VL; Baker DC
    Biochemistry; 1985 Jan; 24(3):641-6. PubMed ID: 3873254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells.
    Agarwal RP
    Biochem Pharmacol; 1980 Feb; 29(2):187-93. PubMed ID: 6965857
    [No Abstract]   [Full Text] [Related]  

  • 11. Degradation of adenosine by extracellular adenosine deaminase in the rat duodenum.
    Franco R; Hoyle CH; Centelles JJ; Burnstock G
    Gen Pharmacol; 1988; 19(5):679-81. PubMed ID: 3265122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
    Smith CM; Belch A; Henderson JF
    Biochem Pharmacol; 1980 Apr; 29(8):1209-10. PubMed ID: 6966932
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
    Parks RE; Dawicki DD; Agarwal KC; Chen SF; Stoeckler JD
    Ann N Y Acad Sci; 1985; 451():188-203. PubMed ID: 3878117
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Johnston JB; Begleiter A; Pugh L; Leith MK; Wilkins JA; Cavers DJ; Israels LG
    Cancer Res; 1986 Apr; 46(4 Pt 2):2179-84. PubMed ID: 2418965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.
    Smith CM; Henderson JF
    Biochem Pharmacol; 1982 Apr; 31(8):1545-51. PubMed ID: 6980005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human malaria parasite adenosine deaminase. Characterization in host enzyme-deficient erythrocyte culture.
    Daddona PE; Wiesmann WP; Lambros C; Kelley WN; Webster HK
    J Biol Chem; 1984 Feb; 259(3):1472-5. PubMed ID: 6363411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition-state stabilization by adenosine deaminase: structural studies of its inhibitory complex with deoxycoformycin.
    Frick L; Wolfenden R; Smal E; Baker DC
    Biochemistry; 1986 Apr; 25(7):1616-21. PubMed ID: 3486673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia.
    Prentice HG; Smyth JF; Ganeshaguru K; Wonke B; Bradstock KF; Janossy G; Goldstone AH; Hoffbrand AV
    Lancet; 1980 Jul; 2(8187):170-2. PubMed ID: 6105339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxicity of deoxycoformycin: effect of constant infusion on adenosine deaminase, adenosine, 2'-deoxyadenosine and monoamines in the mouse brain.
    Helland S; Broch OJ; Ueland PM
    Neuropharmacology; 1983 Jul; 22(7):915-7. PubMed ID: 6604884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Energy metabolism in adenosine deaminase-inhibited human erythrocytes.
    Buc HA; Thuillier L; Hamet M; Garreau F; Moncion A; PĂ©rignon JL
    Clin Chim Acta; 1986 Apr; 156(1):61-9. PubMed ID: 3486057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.